(KRYS) - Analyzing Krystal Biotech's Short Interest
Portfolio Pulse from Benzinga Insights
Krystal Biotech's (NYSE:KRYS) short interest has increased by 21.27% since the last report, with 2.47 million shares sold short, representing 10.15% of its float. This indicates a bearish market sentiment, although it's below the peer group average of 10.60%. The article suggests that an increase in short interest doesn't necessarily predict a price drop.
March 13, 2024 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Krystal Biotech's short interest has increased, indicating a bearish sentiment but remains below its peer average.
The increase in short interest suggests that investors are becoming more bearish on KRYS. However, being below the peer average might mitigate the negative impact slightly. The article implies that high short interest doesn't always lead to a price drop, which adds complexity to predicting the short-term price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90